The scientist’s investigation covers issues in Psychiatry, Atypical hemolytic uremic syndrome, Complement factor I, Immunology and Clinical psychology. His Complement factor I research is multidisciplinary, incorporating elements of Alternative complement pathway and CD46. His Immunology study integrates concerns from other disciplines, such as Mutation, Kidney disease and Renal pathology.
His Mood study in the realm of Clinical psychology interacts with subjects such as Secondary analysis. His study in Genetics is interdisciplinary in nature, drawing from both Molecular biology and Leukodystrophy. His work carried out in the field of Genome-wide association study brings together such families of science as Complement component 4, Disease, Allele, Genetic association and Psychiatric genetics.
David J. Kavanagh mostly deals with Psychiatry, Clinical psychology, Psychological intervention, Mental health and Intervention. His research related to Psychosis, Comorbidity, Cannabis, Substance abuse and Schizophrenia might be considered part of Psychiatry. As a part of the same scientific study, he usually deals with the Clinical psychology, concentrating on Cognition and frequently concerns with Cognitive psychology.
His Psychological intervention research is multidisciplinary, incorporating elements of Psychotherapist and Randomized controlled trial. David J. Kavanagh combines topics linked to Physical therapy with his work on Randomized controlled trial. His Nursing research extends to the thematically linked field of Mental health.
His primary scientific interests are in Atypical hemolytic uremic syndrome, Psychological intervention, Mental health, Clinical psychology and Internal medicine. His research on Atypical hemolytic uremic syndrome is centered around Immunology and Complement system. His Immunology research is multidisciplinary, incorporating perspectives in Haemolytic-uraemic syndrome and Disease.
Factor H and Complement factor I is closely connected to Macular degeneration in his research, which is encompassed under the umbrella topic of Complement system. His research in Mental health intersects with topics in Intervention, Nursing and Medical education. David J. Kavanagh studied Clinical psychology and Anxiety that intersect with Metacognition.
David J. Kavanagh mainly focuses on Atypical hemolytic uremic syndrome, Complement system, Immunology, Thrombotic microangiopathy and Disease. The various areas that he examines in his Atypical hemolytic uremic syndrome study include Eculizumab and Intensive care medicine. His Complement system study focuses mostly on Factor H and Complement factor I.
David J. Kavanagh combines subjects such as Transplantation and Glomerulopathy with his study of Immunology. His study in Disease is interdisciplinary in nature, drawing from both Multifactorial Inheritance, Psychosis, Complement and Genetics. His Dementia study combines topics from a wide range of disciplines, such as Psychiatry and Schizophrenia.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Biological insights from 108 schizophrenia-associated genetic loci
Stephan Ripke;Stephan Ripke;Benjamin M. Neale;Benjamin M. Neale;Aiden Corvin;James T. R. Walters.
De novo mutations in schizophrenia implicate synaptic networks
Menachem Fromer;Andrew Pocklington;David Kavanagh;Hywel John Williams.
Mobile App Rating Scale: A New Tool for Assessing the Quality of Health Mobile Apps
Stoyan R Stoyanov;Leanne Hides;David J Kavanagh;Oksana Zelenko.
Jmir mhealth and uhealth (2015)
Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores
Bjarni J. Vilhjálmsson;Jian Yang;Hilary K. Finucane;Alexander Gusev.
American Journal of Human Genetics (2015)
Recent developments in expressed emotion and schizophrenia.
David J. Kavanagh.
British Journal of Psychiatry (1992)
Imaginary relish and exquisite torture: The elaborated intrusion theory of desire
David J. Kavanagh;Jackie Andrade;Jon May.
Psychological Review (2005)
Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome
Jessica Caprioli;Marina Noris;Simona Brioschi;Gaia Pianetti.
Mood and self-efficacy: Impact of joy and sadness on perceived capabilities
David J. Kavanagh;Gordon H. Bower.
Cognitive Therapy and Research (1985)
Diagnosing postpartum depression in mothers and fathers: whatever happened to anxiety?
Stephen Matthey;Bryanne Barnett;Pauline Howie;David J Kavanagh.
Journal of Affective Disorders (2003)
Eye-movements and visual imagery: A working memory approach to the treatment of post-traumatic stress disorder
Jackie Andrade;David Kavanagh;Alan Baddeley.
British Journal of Clinical Psychology (1997)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: